Abstract 1616: Dissecting the biology and therapeutic vulnerabilities of RB1-mutant osteosarcoma using hereditary retinoblastoma iPSCs Article

Zhu, Dandan, Tu, Jian, Huo, Zijun et al. (2022). Abstract 1616: Dissecting the biology and therapeutic vulnerabilities of RB1-mutant osteosarcoma using hereditary retinoblastoma iPSCs . CANCER RESEARCH, 82(12_Supplement), 1616-1616. 10.1158/1538-7445.am2022-1616

cited authors

  • Zhu, Dandan; Tu, Jian; Huo, Zijun; Xu, An; Huang, Mo-Fan; Liu, Ying; Chen, Yi-Hung; Zhao, Ruiying; Lee, Dung-Fang

authors

publication date

  • June 15, 2022

published in

keywords

  • 2.1 Biological and endogenous factors
  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Biotechnology
  • Cancer
  • Cancer Genomics
  • Genetics
  • Human Genome
  • Orphan Drug
  • Pediatric Cancer
  • Pediatric Research Initiative
  • Rare Diseases
  • Stem Cell Research
  • Stem Cell Research - Induced Pluripotent Stem Cell
  • Stem Cell Research - Induced Pluripotent Stem Cell - Human

Digital Object Identifier (DOI)

publisher

  • American Association for Cancer Research (AACR)

start page

  • 1616

end page

  • 1616

volume

  • 82

issue

  • 12_Supplement